We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+28.53%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$14.3B
AUM Growth
+$4.26B
(+43%)
Cap. Flow
+$1.91B
Cap. Flow
% of AUM
13.37%
Top 10 Holdings %
Top 10 Hldgs %
16.38%
Holding
2,145
New
560
Increased
472
Reduced
391
Closed
662
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
T-Mobile US
TMUS
|
+$139M |
| 2 |
Procter & Gamble
PG
|
+$118M |
| 3 |
Teleflex
TFX
|
+$90.1M |
| 4 |
Microsoft
MSFT
|
+$89.4M |
| 5 |
UBS Group
UBS
|
+$77.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PayPal
PYPL
|
+$203M |
| 2 |
AGN
Allergan plc
AGN
|
+$177M |
| 3 |
MLNX
Mellanox Technologies, Ltd.
MLNX
|
+$118M |
| 4 |
Amazon
AMZN
|
+$115M |
| 5 |
Linde
LIN
|
+$89.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.29% |
| 2 | Consumer Discretionary | 15.87% |
| 3 | Technology | 12.26% |
| 4 | Financials | 12.01% |
| 5 | Industrials | 6.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
826
Exelon
EXC
$48.6B
| $1.79M | 0.01% |
69,229
-24,915
| -26% | -$662K |
|
|
ATRI
827
DELISTED
Atrion Corp
ATRI
| $1.79M | 0.01% |
2,806
-1,221
| -30% | -$798K |
|
|
BPMC
828
DELISTED
Blueprint Medicines
BPMC
| $1.78M | 0.01% |
22,860
-188,146
| -89% | -$12.7M |
|
829
Interactive Brokers
IBKR
$40.9B
| $1.78M | 0.01% |
+170,632
| New | +$1.78M |
|
830
International Seaways
INSW
$4.57B
| $1.77M | 0.01% |
108,319
-27,934
| -21% | -$607K |
|
831
PTC Therapeutics
PTCT
$6.37B
| $1.75M | 0.01% |
+34,576
| New | +$1.7M |
|
|
CZR
832
DELISTED
Caesars Entertainment Corporation
CZR
| $1.75M | 0.01% |
144,577
-1,226,896
| -89% | -$12.4M |
|
833
Magnachip Semiconductor
MX
$128M
| $1.75M | 0.01% |
169,780
-80,915
| -32% | -$902K |
|
834
Afya
AFYA
$1.27B
| $1.74M | 0.01% |
74,356
-76,930
| -51% | -$1.58M |
|
|
WBA
835
DELISTED
Walgreens Boots Alliance
WBA
| $1.73M | 0.01% |
40,771
-289,803
| -88% | -$12.3M |
|
836
Atkore
ATKR
$2.59B
| $1.73M | 0.01% |
63,133
-9,556
| -13% | -$236K |
|
837
Virtu Financial
VIRT
$5.2B
| $1.72M | 0.01% |
+72,933
| New | +$1.7M |
|
838
iShares MSCI Indonesia ETF
EIDO
$476M
| $1.72M | 0.01% |
95,477
+65,045
| +214% | +$1.09M |
|
|
ACC
839
DELISTED
American Campus Communities, Inc.
ACC
| $1.71M | 0.01% |
+49,050
| New | +$1.63M |
|
840
Mondelez International
MDLZ
$77.7B
| $1.71M | 0.01% |
33,338
-291,462
| -90% | -$15M |
|
841
Verisk Analytics
VRSK
$26.4B
| $1.71M | 0.01% |
+10,021
| New | +$1.58M |
|
842
Telephone and Data Systems
TDS
$3.91B
| $1.7M | 0.01% |
85,408
-43,206
| -34% | -$826K |
|
|
RP
843
DELISTED
RealPage, Inc.
RP
| $1.7M | 0.01% |
+26,102
| New | +$1.65M |
|
|
AXDX
844
DELISTED
Accelerate Diagnostics
AXDX
| $1.69M | 0.01% |
11,174
+7,624
| +215% | +$752K |
|
845
10x Genomics
TXG
$5.87B
| $1.69M | 0.01% |
18,900
-39,859
| -68% | -$3.1M |
|
846
Prologis
PLD
$138B
| $1.69M | 0.01% |
18,075
+16,413
| +988% | +$1.46M |
|
|
AMRN
847
Amarin Corp
AMRN
$284M
| $1.69M | 0.01% |
12,177
-15,743
| -56% | -$2.17M |
|
848
Parker-Hannifin
PH
$125B
| $1.67M | 0.01% |
9,132
-10,368
| -53% | -$1.67M |
|
849
Vanguard Consumer Discretionary ETF
VCR
$5.84B
| $1.66M | 0.01% |
8,300
+6,734
| +430% | +$1.21M |
|
850
Televisa
TV
$1.45B
| $1.65M | 0.01% |
315,465
+123,232
| +64% | +$683K |
|
Similar funds
Marshall Wace's Q2 2020 Portfolio in Review
As of Q2 2020, Marshall Wace held 2,145 positions worth $14.3B, up 43% from $10B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Marshall Wace deployed $1.91B of net new capital in Q2 2020, opening 560 new positions and adding to 472 existing holdings. Its largest new stake was JPMorgan Chase: 783,355 shares worth $73.7M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, down from 24% a quarter earlier, followed by Consumer Discretionary and Technology.
On the sell side, the largest reduction was PayPal, an estimated $203M trimmed.
- Marshall Wace's largest Q2 2020 buy was JPMorgan Chase: 783,355 shares worth $73.7M.
- Marshall Wace added most to T-Mobile US in Q2 2020, an estimated $139M increase.
- Marshall Wace's biggest Q2 2020 reduction was PayPal, cutting an estimated $203M.
- Marshall Wace fully exited Allergan plc in Q2 2020, selling an estimated $177M.
- Marshall Wace's ten largest holdings make up 16% of its $14.3B portfolio in Q2 2020.
- Marshall Wace opened 560 new positions and closed 662 in Q2 2020.
- Marshall Wace's portfolio value rose 43% quarter-over-quarter to $14.3B.
Based on Marshall Wace's 13F filing for Q2 2020, filed 13 Aug 2020.